why choose us

First received: April 01, 2023

Clinical Trial: Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Respiratory Tract Diseases

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Brief Summary: Background:Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways.These growths come back when removed; some people may need 2 or more surgeries per year to keep their airways clear.Better treatments are needed.Objective:To see if a drug called bevacizumab can reduce the number of surgeries needed in people with RRP.Eligibility:People aged 18 and older with recurrent RRP; they must need surgery to remove the growths in their airways.Design:Participants will be…

Read more